Elevance Health Inc (NYSE: ELV) is -19.76% lower on its value in year-to-date trading and has touched a low of $379.29 and a high of $567.26 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ELV stock was last observed hovering at around $385.56 in the last trading session, with the day’s loss setting it -7.17%.
Currently trading at $378.39, the stock is -5.03% and -11.26% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.72 million and changing -1.86% at the moment leaves the stock -24.71% off its SMA200. ELV registered -21.74% loss for a year compared to 6-month loss of -29.77%. The firm has a 50-day simple moving average (SMA 50) of $428.9168 and a 200-day simple moving average (SMA200) of $503.22546.
The stock witnessed a -8.36% gain in the last 1 month and extending the period to 3 months gives it a -31.31%, and is -3.71% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.23% over the week and 2.29% over the month.
Elevance Health Inc (ELV) has around 104900 employees, a market worth around $87.76B and $174.01B in sales. Current P/E ratio is 13.79 and Fwd P/E is 10.83. Profit margin for the company is 3.69%. Distance from 52-week low is -0.24% and -33.30% from its 52-week high. The company has generated returns on investments over the last 12 months (9.37%).
The EPS is expected to grow by 0.12% this year
2327.0 institutions hold shares in Elevance Health Inc (ELV), with institutional investors hold 92.00% of the company’s shares. The shares outstanding are 231.93M, and float is at 231.44M with Short Float at 1.22%. Institutions hold 91.82% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 21.21 million shares valued at $11.49 billion. The investor’s holdings represent 9.1134 of the ELV Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 20.7 million shares valued at $11.22 billion to account for 8.8976 of the shares outstanding. The other top investors are PRICE T ROWE ASSOCIATES INC /MD/ which holds 11.65 million shares representing 5.005 and valued at over $6.31 billion, while STATE STREET CORP holds 4.5373 of the shares totaling 10.56 million with a market value of $5.72 billion.
Elevance Health Inc (ELV) Insider Activity
The most recent transaction is an insider sale by Kendrick Charles Morgan JR, the company’s EVP & President, Commercial. SEC filings show that Kendrick Charles Morgan JR sold 7,417 shares of the company’s common stock on Oct 18 ’24 at a price of $432.14 per share for a total of $3.21 million. Following the sale, the insider now owns 8423.0 shares.
Still, SEC filings show that on Aug 05 ’24, PERU RAMIRO G (Director) disposed off 753 shares at an average price of $531.52 for $0.4 million. The insider now directly holds 8,744 shares of Elevance Health Inc (ELV).
